PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS

被引:20
|
作者
Sun, Yanqing [1 ]
Gilbert, Peter B. [2 ,3 ]
McKeague, Ian W. [4 ]
机构
[1] Univ N Carolina, Dept Math & Stat, Charlotte, NC 28223 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98109 USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[4] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10032 USA
来源
ANNALS OF STATISTICS | 2009年 / 37卷 / 01期
基金
美国国家科学基金会;
关键词
Competing risks; distribution-free confidence bands and tests; failure time data; genetic data; HIV vaccine trial; pointwise and simultaneous confidence bands; semiparametric model; survival analysis; COMPETING RISKS; CLINICAL-TRIALS; VACCINE; TIME; COEFFICIENTS;
D O I
10.1214/07-AOS554
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
For time-to-event data with finitely many competing risks, the proportional hazards model has been a popular tool for relating the cause-specific outcomes to covariates [Prentice et al. Biometrics 34 (1978) 541-554]. This article studies an extension of this approach to allow a continuum of competing risks, in which the cause of failure is replaced by a continuous mark only observed at the failure time. We develop inference for the proportional hazards model in which the regression parameters depend nonparametrically on the mark and the baseline hazard depends nonparametrically on both time and mark. This work is motivated by the need to assess HIV vaccine efficacy, while taking into account the genetic divergence of infecting HIV viruses in trial participants from the HIV strain that is contained in the vaccine, and adjusting for covariate effects. Mark-specific vaccine efficacy is expressed in terms of one of the regression functions in the mark-specific proportional hazards model. The new approach is evaluated in simulations and applied to the first HIV vaccine efficacy trial.
引用
收藏
页码:394 / 426
页数:33
相关论文
共 50 条